Himadri Speciality Chemical Limited carries a market capitalization of 323.34B, placing it among publicly traded companies globally. Its enterprise value stands at 255.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 323.34B |
| Enterprise Value | 255.65B |
Himadri Speciality Chemical Limited trades at a trailing price-to-earnings ratio of 41.59.
| PE Ratio | 41.59 |
| PS Ratio | 5.64 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Himadri Speciality Chemical Limited trades at an EV/EBITDA multiple of 23.53 and an EV/FCF ratio of 761.98. The EV/Sales ratio of 5.64 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.53 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.64 |
| EV / EBITDA | 23.53 |
| EV / EBIT | 23.53 |
| EV / FCF | 761.98 |
Himadri Speciality Chemical Limited maintains a current ratio of 6.22, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.48, indicating elevated leverage, while an interest coverage ratio of 22.80 demonstrates strong ability to service its debt obligations.
| Current Ratio | 6.22 |
| Quick Ratio | 0.86 |
| Debt / Equity | 18.48 |
| Debt / EBITDA | N/A |
| Interest Coverage | 22.80 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 89.60 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Himadri Speciality Chemical Limited has paid 2.57B in income taxes, reflecting an effective tax rate of 29.59.
| Income Tax | 2.57B |
| Effective Tax Rate | 29.59 |
Himadri Speciality Chemical Limited's stock has gained approximately 29.98986% over the past 52 weeks. The 50-day moving average sits at 636.50, while the 200-day moving average is 508.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | 29.98986% |
| 50-Day Moving Average | 636.50 |
| 200-Day Moving Average | 508.48 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Himadri Speciality Chemical Limited generated 45.31B in revenue and converted that into 6.15B in net income, yielding earnings per share of 12.28. EBITDA reached 10.86B, while operating income came in at 10.86B.
| Revenue | 45.31B |
| Gross Profit | 15.24B |
| Operating Income | 10.86B |
| Pretax Income | 8.69B |
| Net Income | 6.15B |
| EBITDA | 10.86B |
| EBIT | 10.86B |
| Earnings Per Share (EPS) | 12.28 |
Himadri Speciality Chemical Limited operates with a gross margin of 33.63, reflecting its pricing power and cost economics. The operating margin of 23.98 and net profit margin of 13.57 provide insight into operational efficiency.
| Gross Margin | 33.63 |
| Operating Margin | 23.98 |
| Pretax Margin | 19.17 |
| Profit Margin | 13.57 |
| EBITDA Margin | 23.98 |
Himadri Speciality Chemical Limited's most recent stock split took place on November 8, 2010 with a 1:10 split ratio.
| Last Split Date | 11/8/2010 |
| Split Ratio | 1:10 |
Himadri Speciality Chemical Limited posts an Altman Z-Score of 37.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 37.59 |